Skip to main content
. 2020 Jul 16;105(10):3179–3189. doi: 10.1210/clinem/dgaa448

Table 1.

Participant Characteristics

CF Overall n = 23 Control Overall n = 15 P Values (CF vs Control)
Hypo[+] n = 15 Hypo[–] n = 8 Hypo[+] n = 8 Hypo[–] n = 7 Overall Hypo[+]
Female, n (%) 7 (47) 3 (37.5) 10 (43) 2 (25) 3 (43) 5 (33) 0.54 0.33
Age 25.7 (14.6-30.6) 23.6 (19.2-29.4) 24.8 (14.6-30.6) 25.5 (21-35) 26 (23-38) 26 (21-38) 0.08 0.37
Height (cm) 164.7 (158.7-182.2) 171.2 (161-187) 165 (158.7-186.9) 169.5 (155.5-181) 170 (155.5-186.2) 170 (155.5-186.2) 0.69 0.63
Weight (kg) 61.9 (47.4-78.3) 60.5 (46.4-79.4) 61.9 (46.4-79.4) 72.6 (55.6-87.2) 69.4 (57.6-87.9) 70.8 (55.6-87.9) 0.02 0.09
BMI-z 0.15 (–1.9 to 1.2) 0.12 (–2.4 to 0.51) 0.12 (–2.44 to 1.23) 0.44 (–0.43 to 1.2) 0.66 (–0.3 to 1.2) 0.61 (–0.43 to 1.22) 0.03 0.15
Fasting PG (mg/dL) 88.8 (63.5-113.5) 95.1 (79.3-106.8) 91 (63.5-113.5) 86.5 (75.9-107) 91.2 (86.2-98.9) 88.9 (75.9-107) 0.57 0.69
OGTT 1-hour PG (mg/dL) 196.5 (113-272.5) 210.9 (159-265) 201.5 (113-272.5) 139.8 (69.6-211.5) 133.4 (109-193) 136.8 (69.6-211.5) <0.01 0.02
OGTT 2-hour PG (mg/dL) 121.1 (47.2-197) 192.3 (112-266) 145.9 (47.2-266) 95.5 (60.4-145) 105.1 (88.9-127.5) 99.9 (60.4-145) <0.01 0.11
Normal glucose tolerance 2 (13) - 2 (9) 5 (62) 6 (86) 11 (73)
Early glucose intolerance 7 (47) 1 (13) 8 (35) 2 (25) 1 (14) 3 (20)
Impaired glucose tolerance 6 (40) 4 (50) 10 (43) 1 (13) - 1 (7)
Diabetes - 3 (37) 3 (13) - - -
FEV  1  % predicted 89 (48-128) 74 (32-96) 86 (32-128)
Genotype, n (%) delF508 heterozygous 6 (40) 2 (25) 8 (35)
Genotype, n (%) delF508 homozygous 6 (40) 5 (63) 11 (48)
Modulator therapy, n (%) 9 (60) 6 (75) 15 (65)

Data are expressed as median (minimum-maximum). Comparisons were performed between the CF and Control Overall and Hypo [+] subgroups. Italics represent P < 0.05 for CF-Hypo [+] versus CF-Hypo [–].

Abbreviations: BMI, body mass index; CF, cystic fibrosis; FEV1, forced expiratory volume in 1 second; Hypo, hypoglycemia; OGTT, oral glucose tolerance test; PG, plasma glucose.